original ) (raw )Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry
Morten Hedegaard
Transfusion, 2008
View PDFchevron_right
Fetal hemolytic anemia and intrauterine death caused by anti-M immunization
Agneta Wikman
Transfusion, 2007
View PDFchevron_right
RH D Foeto-Maternal Alloimmunization Prophylaxis with Anti-D Immunoglobulins Reviewed in the Era of Foetalrhdgenotyping
Christiane Gerard
Acta Clinica Belgica, 2009
View PDFchevron_right
Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Shuchita Mundle
Vaccine, 2016
View PDFchevron_right
Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME)
Vesna Čapkun
Transfusion, 2011
View PDFchevron_right
A management programme for Rh alloimmunization during pregnancy
Sergey Lindeberg
Early Human Development, 1987
View PDFchevron_right
Antenatal bleeding: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Isaac Babarinsa
Vaccine, 2017
View PDFchevron_right
Non RhD isoimmunization causing severe hemolytic disease of fetus and newborn in Rh positive pregnancies: report of 2 cases with review of literature
Sangeeta Pahuja
International Journal of Contemporary Pediatrics, 2020
View PDFchevron_right
Haemolytic Disease of the Fetus and Newborn: Past, Present and Future Considerations
Amit Pawar
Acta Scientific Medical Sciences
View PDFchevron_right
Effect of Screening for Red Cell Antibodies, Other Than Anti-D, to Detect Hemolytic Disease of the Fetus and Newborn: A Population Study in The Netherlands
Joke Koelewijn
Obstetrical & Gynecological Survey, 2008
View PDFchevron_right
Comparison of estimation of volume of fetomaternal hemorrhage using Kleihauer-Betke test and microcolumn gel method in D-negative nonisoimmunized mothers
praveen kumar
Immunohematology American Red Cross, 2013
View PDFchevron_right
A case of severe foetal anaemia due to anti-M isoimmunisation salvaged by intrauterine transfusions
anju dubey
Blood transfusion = Trasfusione del sangue, 2014
View PDFchevron_right
The Assessment of Feto-Maternal Hemorrhage in an Artificial Model Using Anti-D and Anti-Fetal Hemoglobin Antibody by Flow Cytometry
alireza andalib
View PDFchevron_right
RhD immunisation in pregnancy
Hans Erik Heier
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2016
View PDFchevron_right
Rh(D) haemolytic disease of the newborn: the changing scene
Suzy Urbaniak
BMJ, 1985
View PDFchevron_right
Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies
Agneta Wikman
Acta Obstetricia et Gynecologica Scandinavica, 2013
View PDFchevron_right
Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn
Roland Devlieger
American journal of obstetrics and gynecology, 2018
View PDFchevron_right
Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities
Morten Hedegaard
Transfusion, 2009
View PDFchevron_right
Haemolytic Disease of the Newborn
Mohammed Mejbahuddin Mia
KYAMC Journal
View PDFchevron_right
Assessment of feto-maternal hemorrhage among rhesus D negative pregnant mothers using the kleihauer-betke test (KBT) and flow cytometry (FCM) in Addis Ababa, Ethiopia
Asaye Mekonnen
BMC Pregnancy and Childbirth, 2014
View PDFchevron_right
Survival in Haemolytic Disease of Newborn Due to Rh-Isoimmunisation: An Unusual Presentation
DR KAFIL AKHTAR
International Journal of Pregnancy & Child Birth
View PDFchevron_right
Consequences for fetus and neonate of maternal red cell allo-immunisation
Cyril Clarke SS
Archives of Disease in Childhood - Fetal and Neonatal Edition, 1998
View PDFchevron_right
High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus
H. Schonewille
American Journal of Obstetrics and Gynecology, 2007
View PDFchevron_right
One single dose of 200 μg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy
Joke Koelewijn
Transfusion, 2008
View PDFchevron_right
The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh (D) alloimmunisation
Angelo Dalessandro
2010
View PDFchevron_right
Survey on the prevention and incidence of haemolytic disease of the newborn in Italy
giuseppe curciarello
Blood Transfusion Trasfusione Del Sangue, 2013
View PDFchevron_right
Prevalence of Red Blood Cell Alloantibodies in Pregnant Women and Hemolytic Disease of Newborn in a Tertiary Care Hospital
Nelly Carpio
ARC Journal of Gynecology and Obstetrics, 2017
View PDFchevron_right
Rhesus-Haemolytic Disease of the Newborn with Reference to Anti-D
Carmelina Borg Cuschieri
2004
View PDFchevron_right
Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP 1 P k or anti-K immunization: a report of two patients
Domingo Hernández
Vox Sanguinis, 2001
View PDFchevron_right